BridgeBio Pharma, Inc. ($BBIO)
Filing Information
| Accession Number | 0001470831-26-000026 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 13, 2026 |
| Document Date | Jan 8, 2026 |
| Document | View SEC Filing |
Transactions
14
Total Shares
80,000
Total Value
$6,043,168.23
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 8, 2026 | Sale | 11,515 | $73.64 | $848,017.57 | 744,171 | Indirect | By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Jan 8, 2026 | Sale | 8,085 | $74.38 | $601,340.47 | 736,086 | Indirect | By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Jan 8, 2026 | Sale | 400 | $75.16 | $30,064.08 | 735,686 | Indirect | By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Jan 8, 2026 | Sale | 11,565 | $73.65 | $851,810.82 | 4,546,882 | Indirect | By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Jan 8, 2026 | Sale | 8,135 | $74.38 | $605,060.96 | 4,538,747 | Indirect | By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Jan 8, 2026 | Sale | 300 | $75.20 | $22,560.99 | 4,538,447 | Indirect | By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Jan 9, 2026 | Sale | 2,151 | $75.75 | $162,942.55 | 733,535 | Indirect | By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Jan 9, 2026 | Sale | 6,955 | $76.72 | $533,568.82 | 726,580 | Indirect | By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Jan 9, 2026 | Sale | 10,519 | $77.61 | $816,364.86 | 716,061 | Indirect | By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Jan 9, 2026 | Sale | 375 | $78.19 | $29,322.00 | 715,686 | Indirect | By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Jan 9, 2026 | Sale | 1,401 | $75.61 | $105,927.93 | 4,537,046 | Indirect | By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Jan 9, 2026 | Sale | 6,067 | $76.53 | $464,289.31 | 4,530,979 | Indirect | By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Jan 9, 2026 | Sale | 10,677 | $77.46 | $827,015.86 | 4,520,302 | Indirect | By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Jan 9, 2026 | Sale | 1,855 | $78.10 | $144,881.99 | 4,518,447 | Indirect | By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. | View Details |